(YOLO) AdvisorShares Pure Cannabis - Ratings and Ratios
Cannabis, Hemp
Description: YOLO AdvisorShares Pure Cannabis
The AdvisorShares Pure Cannabis ETF (YOLO) is an actively managed fund that focuses on investing in companies heavily involved in the marijuana and hemp industry, allocating at least 80% of its net assets to securities of such companies or derivatives with similar economic characteristics. This non-diversified ETF is designed for investors seeking exposure to the cannabis sector.
Given its investment strategy, YOLOs performance is closely tied to the fortunes of the cannabis industry, which has seen significant growth and regulatory changes in recent years. The funds holdings likely include a mix of established players and newer entrants across various segments of the cannabis market, such as cultivation, processing, and retail.
From a technical analysis perspective, YOLOs recent price action indicates a bullish trend, with the short-term Simple Moving Averages (SMA20 and SMA50) trending upwards. However, the long-term SMA200 suggests that the ETF is still below its longer-term trend. The Average True Range (ATR) indicates a relatively high level of volatility, which is not uncommon for a sector-specific ETF like YOLO.
Using the provided technical and fundamental data, a potential forecast for YOLO could be constructed. If we consider the 52-week high and low, along with the current price and SMA trends, its possible that YOLO could continue its upward trend if the cannabis industry maintains its growth momentum. However, the relatively low Assets Under Management (AUM) of $23.79M could imply liquidity risks, and the high volatility (as indicated by the ATR) suggests that investors should be prepared for potential price swings.
Forecasting based on the available data, if YOLO continues to trade above its SMA20 and SMA50, it may be poised for further gains, potentially testing resistance levels near its 52-week high. Conversely, a drop below these moving averages could signal a reversal, with support potentially found around the 52-week low. Investors should closely monitor industry trends, regulatory developments, and the ETFs liquidity when considering an investment in YOLO.
Additional Sources for YOLO ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
YOLO ETF Overview
Market Cap in USD | 25m |
Category | Miscellaneous Sector |
TER | 1.03% |
IPO / Inception | 2019-04-17 |
YOLO ETF Ratings
Growth Rating | -85.2 |
Fundamental | - |
Dividend Rating | 8.16 |
Rel. Strength | -46.7 |
Analysts | - |
Fair Price Momentum | 1.47 USD |
Fair Price DCF | - |
YOLO Dividends
Dividend Yield 12m | 1.87% |
Yield on Cost 5y | 0.43% |
Annual Growth 5y | -24.08% |
Payout Consistency | 80.6% |
Payout Ratio | % |
YOLO Growth Ratios
Growth Correlation 3m | 40.3% |
Growth Correlation 12m | -92.1% |
Growth Correlation 5y | -88.3% |
CAGR 5y | -26.94% |
CAGR/Max DD 5y | -0.28 |
Sharpe Ratio 12m | -0.10 |
Alpha | -50.73 |
Beta | 0.652 |
Volatility | 41.86% |
Current Volume | 29.6k |
Average Volume 20d | 31.1k |
As of July 06, 2025, the stock is trading at USD 1.98 with a total of 29,600 shares traded.
Over the past week, the price has changed by +8.43%, over one month by +0.51%, over three months by +26.20% and over the past year by -39.16%.
No, based on ValueRay´s Analyses, AdvisorShares Pure Cannabis (NYSE ARCA:YOLO) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -85.19 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of YOLO is around 1.47 USD . This means that YOLO is currently overvalued and has a potential downside of -25.76%.
AdvisorShares Pure Cannabis has no consensus analysts rating.
According to our own proprietary Forecast Model, YOLO AdvisorShares Pure Cannabis will be worth about 1.7 in July 2026. The stock is currently trading at 1.98. This means that the stock has a potential downside of -15.15%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1.7 | -15.2% |